BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 20859964)

  • 21. Diphenylprolinol silyl ether as a catalyst in an enantioselective, catalytic michael reaction for the formation of alpha,alpha-disubstituted alpha-amino acid derivatives.
    Hayashi Y; Obi K; Ohta Y; Okamura D; Ishikawa H
    Chem Asian J; 2009 Feb; 4(2):246-9. PubMed ID: 19065594
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synthetic approaches to the neuraminidase inhibitors zanamivir (Relenza) and oseltamivir phosphate (Tamiflu) for the treatment of influenza.
    Magano J
    Chem Rev; 2009 Sep; 109(9):4398-438. PubMed ID: 19537777
    [No Abstract]   [Full Text] [Related]  

  • 23. Synthesis of oseltamivir and tamiphosphor from N-acetyl-D-glucosamine.
    Chen CA; Fang JM
    Org Biomol Chem; 2013 Nov; 11(44):7687-99. PubMed ID: 24108094
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Carbocycles related to oseltamivir as influenza virus group-1-specific neuraminidase inhibitors. Binding to N1 enzymes in the context of virus-like particles.
    Mohan S; McAtamney S; Haselhorst T; von Itzstein M; Pinto BM
    J Med Chem; 2010 Oct; 53(20):7377-91. PubMed ID: 20873795
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Design, synthesis and biological activity of thiazolidine-4-carboxylic acid derivatives as novel influenza neuraminidase inhibitors.
    Liu Y; Jing F; Xu Y; Xie Y; Shi F; Fang H; Li M; Xu W
    Bioorg Med Chem; 2011 Apr; 19(7):2342-8. PubMed ID: 21382719
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Two approaches toward the formal total synthesis of oseltamivir phosphate (Tamiflu): catalytic enantioselective three-component reaction strategy and L-glutamic acid strategy.
    Alagiri K; Furutachi M; Yamatsugu K; Kumagai N; Watanabe T; Shibasaki M
    J Org Chem; 2013 Apr; 78(8):4019-26. PubMed ID: 23517385
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficient synthesis of highly active phospha-isosteres of the influenza neuraminidase inhibitor oseltamivir.
    Carbain B; Collins PJ; Callum L; Martin SR; Hay AJ; McCauley J; Streicher H
    ChemMedChem; 2009 Mar; 4(3):335-7. PubMed ID: 19156651
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Insights from investigating the interaction of oseltamivir (Tamiflu) with neuraminidase of the 2009 H1N1 swine flu virus.
    Wang SQ; Du QS; Huang RB; Zhang DW; Chou KC
    Biochem Biophys Res Commun; 2009 Aug; 386(3):432-6. PubMed ID: 19523442
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pot Economy in the Total Synthesis of Estradiol Methyl Ether by Using an Organocatalyst.
    Hayashi Y; Koshino S; Ojima K; Kwon E
    Angew Chem Int Ed Engl; 2017 Sep; 56(39):11812-11815. PubMed ID: 28749046
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synthesis of six-membered spirocyclic oxindoles with five consecutive stereocenters in an asymmetric organocatalytic one-pot Michael/Michael/aldol addition sequence.
    Zhou B; Yang Y; Shi J; Luo Z; Li Y
    J Org Chem; 2013 Apr; 78(7):2897-907. PubMed ID: 23469872
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Development of a concise synthesis of (-)-oseltamivir (Tamiflu).
    Trost BM; Zhang T
    Chemistry; 2011 Mar; 17(13):3630-43. PubMed ID: 21365707
    [TBL] [Abstract][Full Text] [Related]  

  • 32. New, azide-free transformation of epoxides into 1,2-diamino compounds: synthesis of the anti-influenza neuraminidase inhibitor oseltamivir phosphate (Tamiflu).
    Karpf M; Trussardi R
    J Org Chem; 2001 Mar; 66(6):2044-51. PubMed ID: 11300898
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comment on "Another look at the molecular mechanism of the resistance of H5N1 influenza A virus neuraminidase (NA) to oseltamivir (OTV)".
    Rungrotmongkol T; Malaisree M; Udommaneethanakit T; Hannongbua S
    Biophys Chem; 2009 Apr; 141(1):131-2; author reply 133. PubMed ID: 19231807
    [No Abstract]   [Full Text] [Related]  

  • 34. Analogue inhibitors by modifying oseltamivir based on the crystal neuraminidase structure for treating drug-resistant H5N1 virus.
    Du QS; Wang SQ; Chou KC
    Biochem Biophys Res Commun; 2007 Oct; 362(2):525-31. PubMed ID: 17707775
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An iron carbonyl approach to the influenza neuraminidase inhibitor oseltamivir.
    Bromfield KM; Gradén H; Hagberg DP; Olsson T; Kann N
    Chem Commun (Camb); 2007 Aug; (30):3183-5. PubMed ID: 17653382
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Recent progress in asymmetric bifunctional catalysis using multimetallic systems.
    Shibasaki M; Kanai M; Matsunaga S; Kumagai N
    Acc Chem Res; 2009 Aug; 42(8):1117-27. PubMed ID: 19435320
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Diphenylprolinol silyl ether as a catalyst in an asymmetric, catalytic, and direct michael reaction of nitroethanol with alpha,beta-unsaturated aldehydes.
    Gotoh H; Okamura D; Ishikawa H; Hayashi Y
    Org Lett; 2009 Sep; 11(18):4056-9. PubMed ID: 19739683
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A practical synthesis of (-)-oseltamivir.
    Satoh N; Akiba T; Yokoshima S; Fukuyama T
    Angew Chem Int Ed Engl; 2007; 46(30):5734-6. PubMed ID: 17594704
    [No Abstract]   [Full Text] [Related]  

  • 39. Efficient short step synthesis of Corey's tamiflu intermediate.
    Kipassa NT; Okamura H; Kina K; Hamada T; Iwagawa T
    Org Lett; 2008 Mar; 10(5):815-6. PubMed ID: 18220405
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Desorption electrospray ionization reactions between host crown ethers and the influenza neuraminidase inhibitor oseltamivir for the rapid screening of Tamiflu.
    Nyadong L; Hohenstein EG; Johnson K; Sherrill CD; Green MD; Fernández FM
    Analyst; 2008 Nov; 133(11):1513-22. PubMed ID: 18936828
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.